Milton Mayo Morris - 04 Sep 2026 Form 4 Insider Report for Embecta Corp. (EMBC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Sep 2026, 17:13:52 UTC
Prior SEC filing
04 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeffrey Z. Mann, by POA from Milton Mayo Morris

Key filing fact

Milton Mayo Morris filed Form 4 for Embecta Corp. (EMBC) on 08 Sep 2026.

Key facts

  • This page summarizes Milton Mayo Morris's Form 4 filing for Embecta Corp. (EMBC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Sep 2026, 17:13.

Change

  • Previous filing in this sequence was filed on 04 Sep 2026.
  • Current net transaction value: -$36,971.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001454309 Primary reporting owner

Morris Milton Mayo

Relationship
Director
Address
300 KIMBALL DRIVE, PARSIPPANY
Signature
/s/ Jeffrey Z. Mann, by POA from Milton Mayo Morris
Signature date
08 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EMBC transaction

Common Stock

Sale

Transaction value
$36,971
Shares
-6,293
Change %
-10%
Price
$5.88
Shares after
53,828
Date
04 Sep 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

The Power of Attorney dated November 29, 2023 is incorporated herein by reference.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .